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Foreword
The Department of Health (DH) asked the National Institute for Health and Clinical Excellence
(NICE or the Institute) to produce guidance on brief interventions and referrals to specialist
services to help people who smoke to stop, in particular, pregnant women and people from
disadvantaged groups. It asked the Institute to look at the most effective ways that professionals,
both within and outside the NHS in England, can achieve this.
The Public Health Interventions Advisory Committee (PHIAC) considered both a review of the
evidence and an economic appraisal before developing these recommendations.
This guidance only examines brief smoking cessation interventions. Although important, these
must be seen in the context of a rapidly changing environment.
Publication of the tobacco white paper 'Smoking kills[1]' set out a comprehensive tobacco control
policy for the UK that has seen increased spending on mass media anti-smoking campaigns, a
ban on tobacco advertising and promotion, more prominent health warnings and wider access to
stop smoking services and treatments. In addition, the public health white paper, 'Choosing
health[2]' confirmed that all NHS premises and government departments would be smoke-free
from the end of 2006. It also paved the way for legislation for a ban on smoking in enclosed
public spaces in England by summer 2007.
In light of these changes, the effectiveness of brief interventions should be revisited. In addition,
it will be crucial to monitor the impact of this guidance to determine if it is likely to narrow health
inequalities or, at least, to ensure that it does not widen them.
The impact of wider policy and practice on smoking cessation is already being examined by the
Smoking Cessation Programme Development Group at NICE. Coupled with this guidance on
brief interventions, it will provide both practitioners and policy makers with a comprehensive
evidence-based approach to delivering smoking cessation services in England.
[1] Department of Health (1998) Smoking kills: A white paper on tobacco. London: HMSO.
[2] Department of Health (2004) Choosing health: Making healthier choices easier. London:
Department of Health.
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1 Recommendations
This document constitutes the Institute's formal guidance on brief interventions and referrals for
smoking cessation in primary care and other settings.
The Public Health Interventions Advisory Committee (PHIAC) considered the evidence of
effectiveness and cost effectiveness and comments from stakeholders. The original referral from
the Department of Health made particular reference to pregnant women and vulnerable groups.
However, PHIAC considered that the evidence was insufficient to make specific
recommendations for these groups. The resulting recommendations apply to all smokers.
The recommendations in this section are presented without any reference to evidence
statements. Appendix A repeats all the recommendations and lists their linked evidence
statements.
PHIAC (see appendix C) considered the evidence of effectiveness and cost effectiveness, and
comments from stakeholders and service users.
The methods used to develop the guidance are summarised in appendix D. Details of supporting
documents are given in appendix E.
1.1 Brief interventions in health and community care
Brief interventions involve opportunistic advice, discussion, negotiation or encouragement. They
are commonly used in many areas of health promotion and are delivered by a range of primary
and community care professionals.
For smoking cessation, brief interventions typically take between 5 and 10 minutes and may
include one or more of the following:
simple opportunistic advice to stop
an assessment of the patient's commitment to quit
an offer of pharmacotherapy and/or behavioural support
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provision of self-help material and referral to more intensive support such as the NHS Stop
Smoking Services.
The particular package that is provided will depend on a number of factors, including the
individual's willingness to quit, how acceptable they find the intervention on offer and the
previous ways they have tried to quit. A diagram summarising this care pathway is available
online.
1.1.1 Practice recommendations
Who should receive advice?
Recommendation 1
Everyone who smokes should be advised to quit, unless there are exceptional circumstances[3].
People who are not ready to quit should be asked to consider the possibility and encouraged to
seek help in the future. If an individual who smokes presents with a smoking-related disease, the
cessation advice may be linked to their medical condition.
Recommendation 2
People who smoke should be asked how interested they are in quitting[3]. Advice to stop smoking
should be sensitive to the individual's preferences, needs and circumstances: there is no
evidence that the 'stages of change' model[4] is more effective than any other approach.
Who should advise smokers and how?
Recommendation 3
GPs should take the opportunity to advise all patients[3] who smoke to quit when they attend a
consultation. Those who want to stop should be offered a referral to an intensive support service
(for example, NHS Stop Smoking Services). If they are unwilling or unable to accept this referral
they should be offered pharmacotherapy in line with NICE technology appraisal guidance no. 39[5]
and additional support. The smoking status of those who are not ready to stop should be
recorded and reviewed with the individual once a year, where possible.
Brief interventions and referral for smoking cessation NICE public health guidance 1
© NICE 2006. All rights reserved. Last modified March 2006 Page 6 of 40
Recommendation 4
Nurses in primary and community care should advise everyone who smokes[3] to stop and refer
them to an intensive support service (for example, NHS Stop Smoking Services). If they are
unwilling or unable to accept this referral they should be offered pharmacotherapy by
practitioners with suitable training, in line with NICE technology appraisal guidance no. 39[5], and
additional support. Nurses who are trained NHS stop smoking counsellors may 'refer' to
themselves where appropriate. The smoking status of those who are not ready to stop should be
recorded and reviewed with the individual once a year, where possible.
Recommendation 5
All other health professionals, such as hospital clinicians, pharmacists and dentists, should refer
people who smoke[3] to an intensive support service (for example, NHS Stop Smoking Services).
If the individual is unwilling or unable to accept this referral, practitioners with suitable training
should offer a prescription of pharmacotherapy in line with NICE technology appraisal guidance
no. 39[5], and additional support. Those who are trained NHS stop smoking counsellors may
'refer' to themselves. Where possible, the smoking status of those who are not ready to stop
should be recorded in clinical records and reviewed with the individual once a year, where
possible.
Recommendation 6
Community workers[6] should refer people who smoke[3] to an intensive support service (for
example, NHS Stop Smoking Services). Those who are trained NHS stop smoking counsellors
may 'refer' to themselves.
1.1.2 Strategic recommendations for policy makers, commissioners and
managers
Recommendation 7
Strategic health authorities, NHS hospital trusts, primary care trusts (PCTs), community
pharmacies, local authorities and local community groups should review smoking cessation
policies and practices to take account of the recommendations in this guidance.
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Recommendation 8
Smoking cessation advice and support should be available in community, primary and secondary
care settings for everyone who smokes. Local policy makers and commissioners should target
hard to reach and deprived communities including minority ethnic groups, paying particular
attention to their needs.
Recommendation 9
Monitoring systems should be set up to ensure health professionals have access to information
on the current smoking status of their patients. This should include information on: a) the most
recent occasion on which advice to stop was given, b) the nature of advice offered and c) the
response to that advice.
[3] Occasionally it might be inappropriate to advise a patient to quit: for example, because of their
presenting condition or personal circumstances.
[4] DiClemente CC, Prochaska J. et al. (1991) The process of smoking cessation: An analysis of
precontemplation, contemplation, and preparation stages of change. Journal of Consulting and
Clinical Psychology. Vol 59(2) 295-304.
[5] Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking
cessation. NICE technology appraisal no. 39 (2002). [Replaced by NICE public health guidance
10]
[6] Community workers are practitioners working outside the health sector who have a remit for
smoking cessation.
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2 Public health need and practice
2.1 What is the overall aim of the guidance?
This guidance aims to help local health and social care services as well as the community and
voluntary sectors plan and deliver the most effective and most cost-effective services to
encourage people who smoke to quit.
2.2 Why is it being produced?
Smoking remains the leading cause of preventable morbidity and premature death in England. It
is estimated that between 1998 and 2002, smoking caused an average 86,500 deaths a year.
The prevalence of smoking has declined dramatically since the 1960s, but it still remains
alarmingly high in some groups. These include 20–34 year olds (including women who continue
to smoke through pregnancy), members of some minority ethnic communities and those from
lower socioeconomic groups. Differences in the prevalence of smoking between the higher and
lower social classes accounts for over half the difference in the risk of premature death faced by
these groups[7].
Chewed tobacco products are widely used by some minority ethnic groups. Although less
hazardous than cigarettes, they are still harmful to health and smoking cessation should also be
made available for those who want to quit this habit.
Previous UK guidance has emphasised the importance of offering two forms of smoking
cessation support to achieve the greatest population health benefit:
opportunistic, brief advice to encourage all smokers to quit and to point them to effective
treatments that can help
treatment services for those who would like or need help to stop.
The first option reaches the wider population. The second has a lower reach but higher success
rates. It is thought, however, that brief advice could be key in persuading more smokers to try to
stop[8].
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In the 1998 tobacco white paper 'Smoking kills'[9], the government set out a comprehensive
strategy to reduce tobacco use in the UK. It led to the establishment of the NHS Stop Smoking
Services, the first nationwide stop smoking treatment service in the world, combining
psychological support and medication. The latest results (for April 2004 to March 2005) show
that 529,520 people who had contact with the service had set a quit date – and 297,828 of them
reported that they had stopped smoking 4 weeks after that quit date[10]. There is also evidence
that the service is reaching smokers from disadvantaged socioeconomic groups, although they
have a lower success rate than other socioeconomic groups[11].
Government policy now states that health professionals should refer patients who need support
to the service. This is being reflected in contractual changes:
since 2004, the General Medical Services contract for general practice (the Quality and
Outcomes Framework (QOF)) has awarded points for recording patients' smoking status and
providing cessation advice or referrals. The 'Our health, our care, our say'[12]white paper
outlines plans for the QOF to include wider public health and well-being measures by 2008
from spring 2006, nurses and pharmacists who have undergone special training will be able
to prescribe any licensed medicine, for any medical condition, within their competence[13]
one of the key tasks of NHS-accredited health trainers[14] is to work in the community to
encourage smokers to quit and to refer them to the specialist service[15]. This scheme has
already been set up in disadvantaged areas and will be rolled out nationally by 2007.
2.3 Who is it for?
This guidance is primarily designed for those who commission or work in local health services –
within PCTs, community pharmacies and dental practices – and secondary NHS care, including
mental health and hospital trusts. It also has implications for those working in community
settings, such as health trainers, youth workers and others who may have a role in advising
smokers.
[7] Jarvis M, Wardle J (1999) Social patterning of individual health behaviours: the case of
cigarette smoking. In Marmot M, Wilkinson R, editors Social Determinants of Health. Oxford:
Oxford Press.
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[8] West R (2005) Smoking: Prevalence, mortality and cessation in Great Britain.
[9] Department of Health (1998) Smoking kills: A white paper on tobacco. London: The Stationery
Office.
[10] Department of Health (2005) Statistics on NHS stop smoking services in England, April 2004 to
March 2005. London: Department of Health.
[11] Chesterman et al. (2005) How effective are the English smoking treatment services in reaching
disadvantaged smokers? Addiction 100. (Supplement 2):36-45
[12] Department of Health (2006) Our health, our care, our say: a new direction for community
services. London: The Stationery Office.
[13] See 'Changes to non-medical prescribing' in CMO Update Issue 43, published 11 January
2006.
[14] NHS health trainers are a new workforce to be recruited mainly from the local community,
working in the NHS and other local organisations.
[15] Department of Health (2004) Choosing health: Making healthier choices easier. London:
Department of Health.
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3 Implementation
The Healthcare Commission assesses the performance of NHS organisations in meeting core
and developmental standards set by the DH in 'Standards for better health' issued in July 2004.
The implementation of NICE public health guidance will help organisations meet the standards in
the public health (seventh) domain, such as core standards C22 and C23 and developmental
standard D13. In addition, it will help meet the health inequalities target as set out in 'The NHS in
England: the operating framework for 2006/7'[16].
NICE has developed tools to help organisations implement this guidance (listed below).
Costing tools:
- Costing report to estimate the national savings and costs associated with implementation
- Costing template to estimate the local costs and savings involved.
Implementation advice on how to put the guidance into practice and national initiatives which
support this locally.
Audit criteria to monitor local practice.
[16] Department of Health (2006) The NHS in England: The operating framework for 2006/7.
London: Department of Health.
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4 Background
The processes and methods NICE uses to develop public health guidance are set out in the
following documents, which are available from the NICE website.
'Methods for development of NICE public health guidance (second edition, 2009)'
'The NICE public health guidance development process: An overview for stakeholders
including public health practitioners, policy makers and the public (second edition, 2009)'.
A quick reference guide (QRG) for professionals whose remit includes public health and for
interested members of the public is also available.
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5 Recommendations for research
PHIAC considered that research funding agencies should ensure that a programme is
established to identify the most effective and cost-effective brief interventions for smoking
cessation.
The Committee recommended that the following five key research questions be addressed.
1. Which brief interventions are most effective (and cost effective) for pregnant women and
for people in lower socioeconomic and vulnerable groups – and why?
2. What are the key characteristics of an effective brief intervention for smoking cessation?
3. How effective (and cost effective) – in absolute and relative terms – are brief
interventions delivered by different professionals in a variety of settings?
4. Has the impact of brief interventions changed as a result of increased investment in
tobacco control activities, including development of the NHS smoking cessation
services?
5. Does an individual's previous 'quitting history' affect the success of any subsequent brief
intervention?
Ideally all studies should include short (4 week), medium (3 month) and long term (1 year) follow-
up and biochemical validation.
More detail on the evidence gaps identified during the development of this guidance is provided
in appendix B.
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6 Review
In March 2009 this guidance will be reviewed and the state of the evidence base at that time will
be reassessed. A decision will then be made about whether it is appropriate to update the
guidance. If it is not updated at that time, the situation will be reviewed again in March 2011.
Brief interventions and referral for smoking cessation NICE public health guidance 1
© NICE 2006. All rights reserved. Last modified March 2006 Page 15 of 40
7 Related guidance
Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking
cessation. NICE technology appraisal no. 39 (2002). [Replaced by NICE public health guidance
10]
Smoking cessation services NICE public health guidance 10 (2008)
Brief interventions and referral for smoking cessation NICE public health guidance 1
© NICE 2006. All rights reserved. Last modified March 2006 Page 16 of 40
8 Acknowledgements
This guidance was developed by PHIAC supported by the NICE Project Team.
For details of PHIAC membership see appendix C.
The NICE Project Team comprised:
Mike Kelly
CPHE Director
Antony Morgan
Associate Director
Lesley Owen
Analyst
Patti White
Analyst
Bhash Naidoo
Health Economics Adviser
NICE is grateful for the input of the Academic and Public Health Consortium (APHC)[17], which
carried out the reviews of the evidence of effectiveness, and the Centre for Health Economics
(CHE), University of York, which carried out the cost-effectiveness review. The authors of the
reviews of effectiveness were: Lindsay Stead (University of Oxford), Ann McNeill, Lion Shahab
and Robert West (University College, London). The economic appraisal was undertaken by
Steve Parrott and Christine Godfrey.
NICE would also like to thank the stakeholders who commented on the scope, the evidence base
and the draft recommendations, including those who submitted evidence.
[17] APHC is a collaboration between Action on Smoking and Health (ASH) and University College
London.
Brief interventions and referral for smoking cessation NICE public health guidance 1
© NICE 2006. All rights reserved. Last modified March 2006 Page 17 of 40
Appendix A: recommendations for policy and practice and
supporting evidence statements
This appendix sets out the recommendations and the associated evidence statements taken
from the review of effectiveness (see appendix D for the key to study types and quality
assessments)
Recommendations are followed by the evidence statement(s) that underpin them. The
numbering of the evidence statements reflects the numbering that was used in the brief
interventions review. For example, (evidence statement 1) below is numbered 1 in the brief
interventions review. Where a recommendation is not directly taken from the evidence
statements, but is inferred from the evidence, this is indicated by IDE (inference derived from the
evidence).
The review is available on the NICE website.
Who should receive advice?
Recommendation 1
Everyone who smokes should be advised to quit, unless there are exceptional circumstances[18].
People who are not ready to quit should be asked to consider the possibility and encouraged to
seek help in the future. If an individual who smokes presents with a smoking-related disease, the
cessation advice may be linked to their medical condition.
(IDE)
Recommendation 2
People who smoke should be asked how interested they are in quitting. Advice to stop smoking
should be sensitive to the individual's preferences, needs and circumstances: there is no
evidence that the 'stages of change' model[19] is more effective than any other approach.
(Evidence statement 10 and IDE)
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Who should advise smokers and how?
Recommendation 3
GPs should take the opportunity to advise all patients[18] who smoke to quit when they attend a
consultation. Those who want to stop should be offered a referral to an intensive support service
(for example, NHS Stop Smoking Services). If they are unwilling or unable to accept this referral
they should be offered pharmacotherapy, in line with NICE technology appraisal guidance no.
39[20], and additional support. The smoking status of those who are not ready to stop should be
recorded and reviewed with the individual once a year, where possible.
(Evidence statements 1 and 7)
Recommendation 4
Nurses in primary and community care should advise everyone who smokesto stop and refer
them to an intensive support service (for example, NHS Stop Smoking Services). If they are
unwilling or unable to accept this referral they should be offered pharmacotherapy, in line with
NICE technology appraisal guidance no. 39 and additional support. Nurses who are trained NHS
stop smoking counsellors may 'refer' to themselves where appropriate. The smoking status of
those who are not ready to stop should be recorded and reviewed with the individual once a
year, where possible.
(Evidence statements 2 and 7)
Recommendation 5
All other health professionals, such as hospital clinicians, pharmacists and dentists, should refer
people who smoke[18][20] to an intensive support service (for example, NHS Stop Smoking
Services). If the individual is unwilling or unable to accept this referral, practitioners with suitable
training should offer a prescription of pharmacotherapy, in line with NICE technology appraisal
guidance no. 39[20], and additional support. Those who are trained NHS stop smoking counsellors
may 'refer' to themselves. The smoking status of those who are not ready to stop should be
recorded in clinical records and reviewed with the individual once a year, where possible.
(Evidence statements 1, 2, 7 and 27 and IDE)
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Recommendation 6
Community workers[21] should refer people who smoke to an intensive support service (for
example, NHS Stop Smoking Services). Those who are trained NHS stop smoking counsellors
may 'refer' to themselves.
(Evidence statement 27, IDE)
Strategic recommendations for policy makers,
commissioners and managers
Recommendation 7
Strategic health authorities, NHS hospital trusts, PCTs, community pharmacies, local authorities
and local community groups should review smoking cessation policies and practices to take
account of the recommendations in this guidance.
(IDE)
Recommendation 8
Smoking cessation advice and support should be available in community, primary and secondary
care settings for everyone who smokes. Local policy makers and commissioners should target
hard to reach and deprived communities including minority ethnic groups, paying particular
attention to their needs.
(IDE)
Recommendation 9
Monitoring systems should be set up to ensure health professionals have access to information
on the current smoking status of their patients. This should include information on: a) the most
recent occasion on which advice to stop was given, b) the nature of advice offered and c) the
response to that advice.
(IDE)
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Evidence statements
Evidence statement 1
A body of level 1+ evidence directly applicable to UK health care settings supports the efficacy of
physician advice as a brief intervention for smoking cessation.
Evidence statement 2
A body of level 1+ evidence directly applicable to the UK supports the efficacy of nurse
structured advice as a brief intervention for smoking cessation in primary care and community
settings. However, the primary focus of the contact in these studies was smoking, so these
interventions are not brief opportunistic interventions made during routine care. In addition, poor
uptake of invitations to contact nurses for assistance with smoking cessation was noted in some
UK studies. There is insufficient evidence to say whether opportunistic advice increases quit
rates. A moderately sized body of evidence failed to detect any effect of advice and interventions
delivered by nurses as part of a health check.
Evidence statement 7
A body of level 1+ evidence directly applicable to the UK supports the efficacy of nicotine
replacement therapy (NRT) as part of a brief intervention for smokers wishing to make a quit
attempt.
Evidence statement 10
A moderately sized body of evidence has not found a benefit of stage-matched over unmatched
brief interventions. A moderately sized body of evidence has yielded conflicting results on the
efficacy of stage-matched interventions compared with no intervention.
Evidence statement 27
There is insufficient evidence from direct comparisons to draw firm conclusions about the
influence of the profession of a provider delivering a brief smoking cessation intervention, or the
influence of features of the profession, on intervention effectiveness.
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Cost-effectiveness evidence
Overall, brief interventions were found to be cost effective, and would support the above
recommendations.
The cost-effectiveness analysis demonstrated that brief interventions conducted by GPs and
nurses, in all settings, to all age groups included in the model, and with all adjuncts (NRT, self-
help, telephone helpline) can generate quality-adjusted life year (QALY) gains at a low cost. The
cost per QALY tends to increase as the patient's age increases, but brief interventions delivered
to a 60 year old cohort are still cost effective.
When only comparing the costs of an intervention with no intervention, the estimated incremental
cost per QALY gained varied from around £221 to around £9515, depending on the assumptions
used (see appendix E – the economic analysis modelling report – for further details).
When the healthcare savings are included (as smokers quit smoking and avoid preventable
disease), these are offset by the cost of the intervention. Using this method, the incremental
costs per QALY gained vary from £135 to £6472, depending on the assumptions used.
These variations reflect the results from the sensitivity analysis (regarding the assumptions made
on background quit rates, length of intervention, age of the individual and their level of
dependency).
[18] Occasionally it might be inappropriate to advise a patient to quit; for example because of their
presenting condition or personal circumstances.
[19] DiClemente CC, Prochaska J. et al. (1991) The process of smoking cessation: An analysis of
precontemplation, contemplation, and preparation stages of change. Journal of Consulting and
Clinical Psychology. Vol 59(2) 295-304.
[20] Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking
cessation. NICE technology appraisal no. 39 (2002). [Replaced by NICE public health guidance
10]
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[21] Community workers are practitioners working outside the health sector who have a remit for
smoking cessation.
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Appendix B: gaps in the evidence
PHIAC identified a number of gaps in the evidence related to the specific interventions under
examination. However, this does not mean these are the only research priorities in relation to
smoking cessation activities as a whole. A broader examination of smoking cessation, including
research priorities, will be undertaken as part of the development of NICE's programme guidance
on smoking cessation. The draft scope for this work was published on the NICE website in March
2006.
Specific gaps in the evidence are set out below. These are based on the full set of evidence
statements that can be found in the synopsis and full review.
1. Effectiveness of brief cessation advice in relation to age, gender, socioeconomic status and
ethnicity.
2. Cost effectiveness.
3. Patterns of stop smoking attempts, including the use of aids. In particular:
a. the effectiveness of brief advice with and without cessation aids
b. why brief advice does not work with pregnant smokers
c. the absolute and relative effectiveness of brief advice delivered by different health
professionals, and brief advice and NRT offered by nurses and pharmacists from spring 2006
d. the influence of previous failures to quit on the effectiveness of subsequent brief advice
e. the effectiveness of brief advice delivered via the Internet
f. the effectiveness of brief advice with children and adolescents
g. the effectiveness of brief advice with smokeless tobacco users
h. the effectiveness of brief advice in a range of settings beyond primary care, including A&E
departments, workplaces and community pharmacies
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i. the effectiveness of brief advice of less than 2 minutes
j. the effectiveness of a brief, multi-component intervention based on the five 'A's[22].
4. The effectiveness of brief interventions in light of the wider (and changing) context of tobacco
control in England. This includes greater exposure to mass media anti-smoking campaigns,
wider access to smoking cessation services and more extensive restrictions on smoking in public
places.
The Committee made 5 recommendations for research. These are listed in section 5.
[22] National guidelines define a model brief intervention as consisting of the following questions
and actions: Ask if the person smokes; Advise them to quit; Assess their willingness to make a
quit attempt; Assist them by providing treatment (e.g. behavioural support, NRT or Bupropion)
and arranging follow-up or; Arrange referral to an NHS specialist smoking cessation service.
Raw M, McNeill A, West R (1998) Smoking cessation guidelines for health professionals. A guide
to effective smoking cessation interventions for the healthcare system. Thorax 53: Suppl.
S11-S19.
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Appendix C: membership of the Public Health Interventions
Advisory Committee
NICE has set up a standing committee, the Public Health Interventions Advisory Committee
(PHIAC), which reviews the evidence and develops recommendations on public health
interventions.
Membership of PHIAC is multidisciplinary, comprising public health practitioners, clinicians (both
specialists and generalists), local authority employees, representatives of the public, patients
and/or carers, academics and technical experts as follows.
Mrs Cheryll Adams Professional Officer for Research and Practice Development with the
Community Practitioners' and Health Visitors' Association (CPHVA)
Professor Ron Akehurst Professor of Health Economics and Dean of the School of Health and
Related Research (ScHARR), University of Sheffield
Professor Sue Atkinson Regional Director of Public Health for London. Health Adviser to Mayor
and Greater London Authority
Professor Michael Bury Emeritus Professor of Sociology at the University of London and
Honorary Professor of Sociology at the University of Kent
Professor Simon Capewell Chair of Clinical Epidemiology, University of Liverpool
Professor K K Cheng Professor of Epidemiology, University of Birmingham
Mr Philip Cutler Forums Support Manager, Bradford Alliance on Community Care
Professor Brian Ferguson Director of the Yorkshire and Humber Public Health Observatory
Dr Ruth Hall Director of Public Health for Avon, Gloucestershire and Wiltshire Strategic Health
Authority
Ms Amanda Hoey Director, Consumer Health Consulting Limited
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Mr Andrew Hopkin Senior Assistant Director for Derby City Council
Dr Ann Hoskins Director of Public Health for Cumbria and Lancashire Strategic Health Authority
Professor David R Jones Professor of Medical Statistics in the Department of Health Sciences,
University of Leicester
Dr Matt Kearney General Practitioner, Castlefields, Runcorn. GP Public Health Practitioner,
Knowsley
Ms Valerie King Designated Nurse for Looked After Children for Northampton PCT, Daventry
and South Northants PCT and Northampton General Hospital. Public Health Skills Development
Nurse for Northampton PCT
CHAIR Dr Catherine Law Reader in Children's Health, Institute of Child Health, University
College, London
Ms Sharon McAteer Health Promotion Manager, Halton PCT
Professor Klim McPherson Visiting Professor of Public Health Epidemiology Department of
Obstetrics and Gynaecology, University of Oxford
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Appendix D: summary of the methods used to develop this
guidance
Introduction
The reports of the reviews and economic analysis include full details of the methods used to
select the evidence (including search strategies), assess its quality and summarise it.
The minutes of the PHIAC meetings provide further detail about the Committee's interpretation of
the evidence and development of the recommendations.
All supporting documents are listed in appendix E and are available from the NICE website.
The guidance development process
The stages of the guidance production process are outlined in the box below:
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1. Draft scope
2. Stakeholder meeting
3. Stakeholder comments
4. Final scope and responses published on website
5. Reviews and cost-effectiveness modelling
6. Synopsis report of each review (executive summaries and evidence tables) circulated to
stakeholders for comment
7. Comments and additional material submitted by stakeholders
8. Review of additional material submitted by stakeholders[a]
9. Synopsis, full reviews, supplementary reviews and economic modelling submitted to
PHIAC
10. PHIAC produces draft recommendations
11. Draft recommendations published for comment
12. Responses to comments published
13. PHIAC amends recommendations
14. Final guidance published on website
[a] Submitted material is screened against inclusion criteria used in the reviews.
Key questions
The key questions were established as part of the scope. They formed the starting point for the
reviews of evidence and facilitated the development of recommendations by PHIAC.
1. Which methods of brief intervention are effective? Which methods are most effective? Which
methods are least effective?
2. What are the costs and cost effectiveness associated with brief interventions?
3. What factors affect the effectiveness of brief interventions? Do they differ for different
interventions?
4. Increasing the intensity, duration and/or frequency of a brief intervention can increase
effectiveness. Is this increase additive or multiplicative?
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5. To what extent is the effectiveness of a brief intervention influenced by previously received
brief interventions?
6. To what extent is the effectiveness of a brief intervention influenced by previous quit attempts?
7a. Are some interventions more effective than others within population groups e.g. age within
gender?
7b. Are some interventions more effective than others between population groups for example,
with pregnant women and manual workers?
8. Are interventions tailored to sub-sets of the smoking population (for example, pregnant
women, older smokers) more effective with them than generic interventions?
9. Does the setting/site of delivery of the intervention influence effectiveness?
10. Does the profession of the practitioner providing the intervention influence effectiveness?
What are the significant features?
11. How applicable is what we know about the most effective brief interventions to the most
disadvantaged smokers and pregnant smokers?
12. What are the barriers to delivering smoking cessation interventions?
13. What strategies are effective in encouraging primary care professionals and others to
undertake smoking cessation interventions?
14. What, if any, negative consequences arise from brief interventions?
15. What is the impact on inequalities and health? For example, if a brief intervention is targeted
at the whole population, will it lead to greater inequalities?
Key questions on referral:
1. What factors – training, incentives – influence the number of referrals?
2 What impact, if any, does the PCT have on referrals from primary care to the services?
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3. What factors – mechanisms (e.g. card, fax, telephone, script), role of referrer (e.g. pharmacist,
midwife), type and/or location of service – influence the likelihood of a patient following up the
referral?
4. Does the method of promoting the specialist service (e.g. national advertising, referral from
GPs and other health professionals, word of mouth) influence the number of referrals?
Reviewing the evidence of effectiveness
One review of effectiveness was conducted.
Identifying the evidence
The following databases were searched for recent systematic reviews (2000–August 2005) and
for trials (1985–August 2005): MEDLINE, Cochrane Database of Systematic Reviews, Cochrane
Controlled Trials Register (CENTRAL), Cochrane Tobacco Addiction Group Specialised Register,
Reference Manager, DARE, ASSIA, British Nursing Index, Embase, Cinahl, PsycINFO
Sociological Abstracts.
Additional searches using the same databases were conducted for information on barriers to
implementation and for the question on referrals to NHS smoking services. In addition, a call for
information on referrals was put out on Globalink UK, an international network of over 1000
tobacco control activists, smoking cessation workers and researchers. (This includes most
smoking cessation coordinators in England.) Regional stop smoking service managers were also
asked for referral data. Full details of the databases and search strategies can be found in the
full effectiveness review.
Details of the search terms and strategies are included in the rapid review report.
Selection criteria
Reviews were excluded by two reviewers if:
the title or abstract did not primarily address smoking cessation
the study was clearly not conducted systematically
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the study did not address any of the scope questions (in such cases lower level evidence
was sought).
A similar process was used to exclude trials and other types of research studies. For these
studies one reviewer judged the potential relevance of the evidence. Consistency of coding was
assessed in a subset of 80 papers and a kappa of >0.6 obtained for inclusion versus exclusion.
Papers where there was uncertainty about the intervention's classification were retained.
Quality appraisal
Included papers were assessed for methodological rigour and quality using the NICE
methodology checklist, as set out in the NICE technical manual 'Guideline development
methods[23]'. Each study was described by study type (categorised as types 1-4) and graded (++,
+, -) to reflect the risk of potential bias arising from its design and execution:
Study type
1. Meta-analyses, systematic reviews of RCTs or RCTs (including cluster RCTs).
2. Systematic reviews of, or individual, non-randomised controlled trials, case-control studies,
cohort studies, controlled before-and-after (CBA) studies, interrupted time series (ITS) studies,
correlation studies.
3. Non-analytical studies (for example, case reports, case series).
4. Expert opinion, formal consensus.
Study quality
++ All or most of the criteria have been fulfilled. Where they have not been fulfilled the
conclusions are thought very unlikely to alter.
+ Some criteria have been fulfilled. Those criteria that have not been fulfilled or not adequately
described are thought unlikely to alter the conclusions.
- Few or no criteria fulfilled. The conclusions of the study are thought likely or very likely to alter.
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Study type and quality were described together, for example, as (1++) or (2-). The studies were
also assessed for their applicability to the UK.
Summarising the evidence and making evidence statements
The review data was summarised in evidence tables (see full reviews and the synopsis).
Outcomes of interest included non-validated and validated smoking status (such as, self-reported
smoking abstinence and bio-chemically validated smoking abstinence such as saliva cotinine).
Trials that included follow-ups of six months or more were the primary focus. Trials of shorter
duration were included where necessary.
The findings from the review were synthesised and used as the basis for a number of evidence
statements relating to each key question. The evidence statements reflect the strength (quantity,
type and quality) of evidence and its applicability to the populations and settings in the scope.
Economic appraisal
The economic appraisal consisted of a review of economic evaluations and a cost-effectiveness
analysis.
Review of economic evaluations
A systematic search was carried out on 9 databases from January 1985 to August 2005:
CINAHL, Cochrane Library, DARE, EMBASE, NHS HEED, NEED, HMIC, MEDLINE and
PSYCINFO.
Where available, abstracts were used to identify papers that might be relevant to the review as
appraised by two reviewers. Papers which included, or potentially included, cost-effectiveness
results were identified and full copies obtained.
Studies were excluded if they:
did not contain any original evidence
did not report the costs (or cost effectiveness) of interventions
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reported on interventions comprising more than one session (other than brief follow-up
contacts).
Included studies were assessed for quality using a checklist based on the criteria developed by
Drummond et al. (1997)[24]. Inclusion of QALYs as an outcome measure was essential at this
stage. As with the review of effectiveness, studies were then given a score (++, +, -) to reflect the
risk of potential bias arising from its design and execution. The evidence tables for the cost-
effectiveness review are included in the review (see appendix E).
Cost-effectiveness analysis
A cost-effectiveness analysis was carried out for brief interventions in primary care.
An economic model was constructed to incorporate data from the reviews of effectiveness and
cost effectiveness. The aim was to estimate the average QALYS gained over the simulation time
period. The estimates were based on the estimated 12 month quit rates taken from the review of
effectiveness. The estimates were calculated for different ages and gender of the population
cohort. Because of the limited nature of the evidence a wide range of sensitivity analyses were
performed.
A number of assumptions were made which could underestimate or overestimate the cost per
QALY (see modelling report for further details).
How PHIAC formulated the recommendations
At its meeting in January 2006, PHIAC considered the evidence of effectiveness and cost
effectiveness and comments from stakeholders to determine:
whether there was sufficient evidence (in terms of quantity, quality and applicability) to form
a judgement
whether, on balance, the evidence demonstrates that the intervention is effective or
ineffective, or whether it is equivocal
where there is an effect, the typical size of effect.
PHIAC developed draft recommendations through informal consensus, based on the following
criteria.
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Strength (quality and quantity) of evidence of effectiveness and its applicability to the
populations/settings referred to in the scope.
Effect size and potential impact on population health and/or reducing inequalities in health.
Cost effectiveness (for the NHS and other public sector organisations).
Balance of risks and benefits.
Ease of implementation and the anticipated extent of change in practice that would be
required.
PHIAC noted that the effectiveness of some interventions could vary according to the context in
which they were delivered. For example, the social acceptability of smoking in a particular
community might affect the way an intervention was received.
PHIAC also considered whether research should be a condition for a recommendation where
evidence was lacking.
Where possible, recommendations were linked to an evidence statement(s) – see appendix A for
details. Where a recommendation was inferred from the evidence, this was indicated by the
reference 'IDE' (inference derived from the evidence).
The draft guidance, including the recommendations, was released for consultation in January/
February 2006. PHIAC met in February 2006 to consider stakeholder comments and to revise
the recommendations accordingly. The guidance was signed off by the NICE Guidance
Executive in March 2006.
[23] National Institute for Clinical Excellence (2005) Guideline development methods. London:
National Institute for Clinical Excellence.
[24] Drummond MF, et al. (1997) Critical assessment of economic evaluation. In Methods for the
Economic Evaluation of Health Care Programmes. 2nd edition. Oxford: Oxford Medical
Publications.
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Appendix E: supporting documents
Supporting documents are available from the NICE website. These include the following.
Review of effectiveness.
Economic analysis: rapid review and modelling report.
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Changes after publication
February 2012: minor maintenance.
February 2013: minor maintenance.
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About this guidance
NICE public health guidance makes recommendations on the promotion of good health and the
prevention of ill health.
This guidance was developed using the NICE public health intervention guidance process.
The recommendations from this guidance have been incorporated into a NICE Pathway. Tools to
help you put the guidance into practice and information about the evidence it is based on are
also available.
Your responsibility
This guidance represents the views of the Institute and was arrived at after careful consideration
of the evidence available. Those working in the NHS, local authorities, the wider public, voluntary
and community sectors and the private sector should take it into account when carrying out their
professional, managerial or voluntary duties.
Implementation of this guidance is the responsibility of local commissioners and/or providers.
Commissioners and providers are reminded that it is their responsibility to implement the
guidance, in their local context, in light of their duties to avoid unlawful discrimination and to have
regard to promoting equality of opportunity. Nothing in this guidance should be interpreted in a
way which would be inconsistent with compliance with those duties.
Copyright
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for commercial purposes, is allowed without the written permission of NICE.
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